Andrea Kew

715 total citations
25 papers, 290 citations indexed

About

Andrea Kew is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Andrea Kew has authored 25 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Andrea Kew's work include Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (7 papers) and Protein Degradation and Inhibitors (4 papers). Andrea Kew is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (7 papers) and Protein Degradation and Inhibitors (4 papers). Andrea Kew collaborates with scholars based in Canada, United Kingdom and United States. Andrea Kew's co-authors include J. G. Daly, Darrell White, Stephen Couban, Ward Patrick, Kara Thompson, G. Olivier, S G Griffiths, Arleigh McCurdy, Mitchell Sabloff and Jane F. Apperley and has published in prestigious journals such as Blood, AIDS and British Journal of Haematology.

In The Last Decade

Andrea Kew

24 papers receiving 282 citations

Peers

Andrea Kew
A. Insunza Spain
Josefina Serrano Spain
Arzu Akçay Türkiye
Fengkui Zhang China
Sachin David India
H Matsukura Japan
Dante A. Suffredini United States
M. L. Turner United Kingdom
Yuju Ohno Japan
Aïcha Ait Soussan Netherlands
A. Insunza Spain
Andrea Kew
Citations per year, relative to Andrea Kew Andrea Kew (= 1×) peers A. Insunza

Countries citing papers authored by Andrea Kew

Since Specialization
Citations

This map shows the geographic impact of Andrea Kew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Kew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Kew more than expected).

Fields of papers citing papers by Andrea Kew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Kew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Kew. The network helps show where Andrea Kew may publish in the future.

Co-authorship network of co-authors of Andrea Kew

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Kew. A scholar is included among the top collaborators of Andrea Kew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Kew. Andrea Kew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Venner, Christopher P., Richard LeBlanc, Irwindeep Sandhu, et al.. (2021). Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN‐003/MYX.1 single arm phase II trial. American Journal of Hematology. 96(5). 552–560. 12 indexed citations
2.
3.
Venner, Christopher P., Donna Reece, Andrea Kew, et al.. (2020). Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature. Clinical Lymphoma Myeloma & Leukemia. 20(11). e791–e800. 10 indexed citations
4.
Reece, Donna, Andrea Kew, Marc Lalancette, et al.. (2019). Unusual Carfilzomib Toxicity: Three Cases of Drug-induced Thrombotic Microangiopathy (TMA) after Treatment with High-dose weekly Carfilzomib, Cyclophosphamide, and Dexamethasone (wCCD). Clinical Lymphoma Myeloma & Leukemia. 19(10). e272–e273. 4 indexed citations
5.
6.
McCudden, Christopher R., et al.. (2017). Synoptic reporting for protein electrophoresis and immunofixation. Clinical Biochemistry. 51. 21–28. 9 indexed citations
7.
Medeiros, Bruno C., Suman Kambhampati, Daniel A. Pollyea, et al.. (2017). Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia. Haematologica. 103(1). 101–106. 17 indexed citations
8.
9.
10.
Conrad, David, et al.. (2014). A case of congenital TTP presenting with microganiopathy in adulthood. PubMed. 14(1). 16–16. 3 indexed citations
11.
Meier‐Stephenson, Vanessa, et al.. (2014). Effects of a Pharmacy-Driven Perisplenectomy Vaccination Program on Vaccination Rates and Adherence to Guidelines. The Canadian Journal of Hospital Pharmacy. 67(4). 262–7. 5 indexed citations
12.
13.
Paulson, Kristjan, Pascal Lambert, Julie Bergeron, et al.. (2014). Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study. British Journal of Haematology. 166(5). 660–666. 38 indexed citations
14.
Cox, Ashley, Saul Offman, Jennifer Merrimen, Andrea Kew, & Richard W. Norman. (2013). Bilateral renal sinus myelolipomas. Canadian Urological Association Journal. 4(6). 164–164. 9 indexed citations
15.
Brandwein, Joseph, Michelle Geddes, Jeannine Kassis, et al.. (2013). Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus.. PubMed. 3(2). 141–64. 12 indexed citations
16.
Kew, Andrea, Darrell White, & Kathryn Slayter. (2008). Survey of Vaccine Administration to Splenectomized Patients: Are Guidelines Being Followed?. Canadian Journal of Infectious Diseases and Medical Microbiology. 19(2). 206–206. 3 indexed citations
17.
Gabriel, Ian, Jane F. Apperley, Mark Bower, et al.. (2008). A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins disease. AIDS. 22(4). 539–540. 6 indexed citations
18.
Kew, Andrea, Stephen Couban, Ward Patrick, Kara Thompson, & Darrell White. (2006). Outcome of Hematopoietic Stem Cell Transplant Recipients Admitted to the Intensive Care Unit. Biology of Blood and Marrow Transplantation. 12(3). 301–305. 35 indexed citations
19.
Daly, J. G., et al.. (2001). Characterization of attenuated Renibacterium salmoninarum strains and their use as live vaccines. Diseases of Aquatic Organisms. 44(2). 121–126. 23 indexed citations
20.
Daly, J. G., et al.. (1996). The cell surface ofAeromonas salmonicidadeterminesin vitrosurvival in cultured brook trout (Salvelinus fontinalis) peritoneal macrophages. Microbial Pathogenesis. 21(6). 447–461. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Insunza Breakdown of academic impact, for papers by Josefina Serrano Breakdown of academic impact, for papers by Arzu Akçay Breakdown of academic impact, for papers by Fengkui Zhang Breakdown of academic impact, for papers by Sachin David Breakdown of academic impact, for papers by H Matsukura Breakdown of academic impact, for papers by Dante A. Suffredini Breakdown of academic impact, for papers by M. L. Turner Breakdown of academic impact, for papers by Yuju Ohno Breakdown of academic impact, for papers by Aïcha Ait Soussan
Rankless by CCL
2026